| MIRUM PHARMACEUTICALS |
| USA |
| Gesundheit |
| US6047491013 / A2PM29 |
| 08D (Frankfurt) / MIRM (NASDAQ) |
| FRA:08D, ETR:08D, 08D:GR, NASDAQ:MIRM |
| - |
| https://mirumpharma.com/ |
|
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for rare diseases. Its primary objective is to address unmet medical needs, par..
>Volltext.. |
| 4843.45 Mio. EUR |
| 4789.26 Mio. EUR |
| 451.69 Mio. EUR |
| 1.83 Mio. EUR |
| -20.24 Mio. EUR |
| -0.41 EUR |
| 276.79 Mio. EUR |
| 257.06 Mio. EUR |
| 48.37 Mio. EUR |
| 1.86 |
| 36.39% |
| 76.58% |
| - |
| - |
| - |
| - |
| MIRUM |
| 18.03.26 |